TRATAMENTO MEDICAMENTOSO PARA GESTANTES COM PRÉ-ECLÂMPSIA: UMA REVISÃO INTEGRATIVA DA LITERATURA

Abstract

Pregnancy is a unique and important moment in a woman's life, where the body goes through changes, which can cause new health problems. One of the most frequent diseases during this period is pre-eclampsia, a hypertensive disease specific to pregnancy, which brings the worst results for mothers and their babies, being responsible for around 5% to 17% of maternal deaths, which brings the need of a safe and effective pharmacological treatment. The present study aims to carry out an integrative review of the literature on the drug treatment of pre-eclampsia. However, the study used the following databases: PubMed, Virtual Health Library and Science Direct, the search totaled 403 articles, two of which were chosen following the exclusion and inclusion criteria, in addition to having been carried out in 2006 and 2018. To For the pregnancy of women diagnosed with pre-eclampsia to occur without unwanted complications, it is necessary to define a treatment and follow it. The most recommended medications are: methyldopa, long-acting nifedipine and labetalol. The definition of therapy will depend on the doctor's familiarity with the drug and gestational conditions. These medications play indispensable roles in providing a comprehensive range of options for controlling high blood pressure in pregnant women with preeclampsia. However, the scarcity of articles found that address this topic is notable; therefore, it is suggested that other studies be developed on this extremely important subject, so that maternal and perinatal mortality decreases in Brazil and around the world.